80 Participants Needed

Exercise Snacks for Type 2 Diabetes

JP
Overseen ByJonathan P Little, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, you must be on a stable dose of up to 3 glucose-lowering medications (not including insulin) and up to 2 cardiovascular medications for more than 6 months to participate.

What data supports the effectiveness of the treatment 'Exercise Snacks' for Type 2 Diabetes?

Research shows that regular physical exercise, including small doses of intense exercise before meals, can improve blood sugar control and increase insulin sensitivity in people with type 2 diabetes. Exercise is also known to reduce body fat, improve heart health, and enhance overall fitness, making it a beneficial treatment for managing diabetes.12345

Is it safe for humans to participate in exercise snacks or similar physical activity interventions?

Exercise snacks and similar physical activities are generally safe for humans, but it's important to monitor glucose levels, especially for people with diabetes. Light to moderate exercise is recommended, while high-intensity exercise may cause wide glucose fluctuations. People with diabetes should consult healthcare providers to tailor exercise plans to their specific needs and conditions.12678

How is the 'Exercise Snacks' treatment different from other treatments for type 2 diabetes?

The 'Exercise Snacks' treatment is unique because it involves short, intense bursts of exercise before meals, which can improve blood sugar control more effectively than longer, moderate exercise sessions. This approach is convenient, easy to implement, and helps reduce sedentary time, making it a practical option for people with busy schedules.124910

What is the purpose of this trial?

To conduct a pilot randomized control trial to determine the feasibility of a 12-week, technology-enabled exercise snacks intervention in adults living with type 2 diabetes in a real-world setting. We will also assess preliminary efficacy based on measures of glycemic control and fitness.

Research Team

JL

Jonathan Little, PhD

Principal Investigator

University of British Columbia

Eligibility Criteria

Adults aged 30-75 with type 2 diabetes, HbA1c ≤8.5%, physically inactive, and not on extreme diets or certain medications can join this study. They must be able to use technology for the program and not have conditions like severe heart disease, recent cardiovascular events, or psychiatric disorders that interfere with exercise.

Inclusion Criteria

HbA1c ≤8.5%
Able to maintain current physical activity patterns during the study
Physically inactive (performing <150 min moderate-to-vigorous physical activity per week)
See 8 more

Exclusion Criteria

I am taking beta-blockers that may affect heart rate tests.
Angina upon exertion assessed by the Rose Angina Questionnaire
I have a heart or lung condition that stops me from exercising.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-intervention Meeting

Participants have a meeting to document physical limitations and discuss the prescribed intervention

1 week
1 visit (in-person or virtual)

Treatment

Participants perform either vigorous-intensity bodyweight exercises or low-intensity stretching exercises for 12 weeks

12 weeks
Delivered via app or web platform

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
1 visit (in-person)

Treatment Details

Interventions

  • Exercise Snacks
Trial Overview The trial is testing 'exercise snacks,' short bursts of physical activity facilitated by technology over a period of 12 weeks. Participants are randomly placed into two groups: one doing these exercises and another performing placebo activities to compare effects on blood sugar control and fitness.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise SnacksExperimental Treatment1 Intervention
Vigorous-intensity bodyweight exercises performed 4 times per day on at least 5 days per week.
Group II: Placebo ExerciseActive Control1 Intervention
Low-intensity stretching exercises performed 4 times per day on at least 5 days per week.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

McMaster University

Collaborator

Trials
936
Recruited
2,630,000+

Findings from Research

Short bursts of intense exercise ('exercise snacks') before meals significantly improved blood glucose control in individuals with insulin resistance, showing a reduction in post-meal glucose levels compared to traditional continuous exercise.
Both exercise snacking and a combination of exercise snacking with resistance training were equally effective in lowering overall glucose levels, suggesting that brief, intense workouts can be a practical strategy for managing blood sugar.
'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance.Francois, ME., Baldi, JC., Manning, PJ., et al.[2022]
Regular physical exercise is crucial for both preventing and treating type 2 diabetes, leading to benefits such as improved insulin sensitivity, better glycemic control, and enhanced cardiovascular health.
Before starting an exercise program, individuals with type 2 diabetes should undergo a thorough medical evaluation to assess their cardiovascular health and any complications, ensuring a safe and effective exercise plan that gradually increases in intensity.
Diet and exercise in type 2 diabetes mellitus.Hamdy, O., Goodyear, LJ., Horton, ES.[2019]
In a 3-year study involving 300 patients with type 2 diabetes, behavioral counseling led to significant increases in physical activity and decreases in sedentary time, which were associated with improved physical fitness and reduced cardiovascular risk factors.
Modest increases in moderate- to vigorous-intensity physical activity (MVPA) resulted in clinically meaningful improvements, such as a decrease in HbA1c levels and enhanced cardiorespiratory fitness, highlighting the importance of even small changes in activity levels.
Relationships of Changes in Physical Activity and Sedentary Behavior With Changes in Physical Fitness and Cardiometabolic Risk Profile in Individuals With Type 2 Diabetes: The Italian Diabetes and Exercise Study 2 (IDES_2).Balducci, S., Haxhi, J., Sacchetti, M., et al.[2023]

References

'Exercise snacks' before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. [2022]
Diet and exercise in type 2 diabetes mellitus. [2019]
Relationships of Changes in Physical Activity and Sedentary Behavior With Changes in Physical Fitness and Cardiometabolic Risk Profile in Individuals With Type 2 Diabetes: The Italian Diabetes and Exercise Study 2 (IDES_2). [2023]
Effects of Acute Resistance Exercise with and without Whole-Body Electromyostimulation and Endurance Exercise on the Postprandial Glucose Regulation in Patients with Type 2 Diabetes Mellitus: A Randomized Crossover Study. [2022]
Exercise Therapy for Patients With Type 2 Diabetes: A Narrative Review. [2020]
Exercising Tactically for Taming Postmeal Glucose Surges. [2023]
Programming pre-exercise snacks to prevent post-exercise hypoglycemia in intensively treated insulin-dependent diabetics. [2019]
Resources to Guide Exercise Specialists Managing Adults with Diabetes. [2020]
Glycemic and insulinemic responses to different preexercise snacks in participants with impaired fasting glucose. [2019]
10.China (Republic : 1949- )pubmed.ncbi.nlm.nih.gov
[Applying an Exercise Snack-Based Health Promotion Strategy]. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security